Modern Pharmaceuticals' Sales Revenue Increases Significantly
This article was originally published in PharmAsia News
Executive SummaryBased on Modern Pharma's increased sales of cardiovascular drugs, antibiotics, and generic drugs, investment advisors claim the company's performance has risen to a new level
You may also be interested in...
Richard Pazdur, FDA's oncology chief, reiterates the breakthrough therapy designation is for agency-sponsor communication and not an investor tool.